About the GHIT Fund


Press Room

Announcement of GHIT Fund RFP Hit-to-Lead Platform 2014-001

2014.03.17
The GHIT Fund today annouced a new program "Hit-to-Lead Platform(HTLP)". 
 
The GHIT Fund endeavors to further facilitate collaboration & funding of global health R&D, to build momentum, and to demonstrate action and results. The HTLP is designed to leverage the PDPs’ active platform for neglected and tropical diseases in partnership with Japanese companies or academic organizations that have relevant compounds.
 
The HTLP projects will focus on the aspect of the drug discovery and development process that progresses hits, identified through compound library screening, into lead compounds that can then be optimized into drug candidates. This platform will provide a bridge from early drug discovery into our typical Grant-making Mechanism that begins at the lead-optimization step.
 
For more details, please go to Funding Opportunities.
Ark Hills Sengokuyama Mori Tower 25F, 1-9-10 Roppongi, Minato-ku, Tokyo 106-0032
TEL:+81-36441-2032 FAX:+81-36441-2031 E-mail:info@ghitfund.org